Universal Time: 14:40  |  Local Time: 14:40 (3h GMT)
Select your timezone:

Thematic Session
Clinical trials design and end-points in transplantation

Monday September 23, 2024 | 15:40 to 16:40
Room: TBD
Track: N/A


Quality clinical trials are required to inform clinical practice and policy changes as they are the best form of evidence that can minimise the effect of bias. However, conducting clinical trials in transplantation is often challenging owing to the nature of the disease, complexity of the transplant population and the variability and heterogeneity of outcome measures. Here, our experts will discuss the potential novel trial designs, the use of novel end-points, and the ethical issues surrounding the design and conduct of clinical trials in transplantation.

Social Media Promotion Image

right-click to download


Andrea Viecelli, Australia
Innovative trial design in transplantation

Jayme Locke, United States
The Parsons Model - ethical implications of research involving those determined dead by neurological criteria

Roslyn B. Mannon, United States
Trials in immunosuppression/Long term in kidney transplantation

© 2024 TTS 2024